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The unfolded protein response (UPR) responds to disruption of endoplasmic reticulum
(ER) function by initiating signaling cascades that ultimately culminate in extensive
transcriptional regulation. Classically, this regulation includes genes encoding ER
chaperones, ER-associated degradation factors, and others involved in secretory protein
folding and processing, and is carried out by the transcriptional activators that are produced
as a consequence of UPR activation. However, up to half of the mRNAs regulated by ER
stress are downregulated rather than upregulated, and the mechanisms linking ER stress
and UPR activation to mRNA suppression are poorly understood. To begin to address
this issue, we used a “bottom-up” approach to study the metabolic gene regulatory
network controlled by the UPR in the liver, because ER stress in the liver leads to lipid
accumulation, and fatty liver disease is the most common liver disease in the western
world. qRT-PCR profiling of mouse liver mRNAs during ER stress revealed that suppression
of the transcriptional regulators C/EBPα, PPARα, and PGC-1α preceded lipid accumulation,
and was then followed by suppression of mRNAs encoding key enzymes involved in fatty
acid oxidation and lipoprotein biogenesis and transport. Mice lacking the ER stress sensor
ATF6α, which experience persistent ER stress and profound lipid accumulation during
challenge, were then used as the basis for a functional genomics approach that allowed
genes to be grouped into distinct expression profiles. This clustering predicted that ER
stress would suppress the activity of the metabolic transcriptional regulator HNF4α—a
finding subsequently confirmed by chromatin immunopreciptation at the Cebpa and Pgc1a
promoters. Our results establish a framework for hepatic gene regulation during ER stress
and suggest that HNF4α occupies the apex of that framework. They also provide a unique
resource for the community to further explore the temporal regulation of gene expression
during ER stress in vivo.
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INTRODUCTION
Originally identified as a program for improving protein fold-
ing during ER stress, the vertebrate UPR is composed of
three separate but functionally overlapping pathways that cul-
minate in transcriptional upregulation of genes involved in
ER protein folding and processing (Ron and Walter, 2007).
The ER-resident endoribonuclease IRE1, which is conserved
among eukaryotes and exists as α [GenBank:NM_023913.2]
and β [GenBank:NM_012016.2] paralogs in mammals, cat-
alyzes splicing of Xbp1 mRNA [GenBank:NM_013842.3 and
NM_001271730.1] to remove a 26 base intron and allow
for the translation of a transcriptional activator of the
bZIP family. The PERK kinase [GenBank:NM_010121.2] is
Abbreviations: bZIP, basic leucine zipper; ER, endoplasmic reticulum; TM, tuni-
camycin; UPR, unfolded protein response; VLDL, very low density lipoprotein.
metazoan-specific, and it phosphorylates the translation initia-
tion factor eIF2α [GenBank:NM_001005509.2] when activated,
resulting in transient inhibition of protein synthesis but also
specific translation of Atf4 mRNA [GenBank:NM_009716.2] to
produce the bZIP transcriptional activator ATF4. Other ER stress-
independent eIF2α kinases exist, and phophorylation of eIF2α
and the attendant consequences of that event are known as the
integrated stress response. ATF6, also metazoan-specific and with
α [GenBank:NM_007348.3] and β [GenBank:NM_017406.4]
paralogs, is resident to the ER but transits to the Golgi during
stress, where it is cleaved by regulated intramembrane proteolysis
to liberate an active bZIP transcriptional activator. Together, these
bZIPs coordinate enhancement of protein synthesis, degradation,
folding, modification, and trafficking through gene regulation.
An oft overlooked feature of UPR activation is that between
20 and 50 percent of regulated genes are actually suppressed
by ER stress depending on the conditions, yet much less is
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known about the mechanisms responsible for this suppression
and the physiological consequences thereof. A portion of this
suppression can be attributed to regulated IRE1-dependent
decay, in which the IRE1 endonuclease degrades ER-associated
mRNAs (Hollien and Weissman, 2006). Transcriptional mech-
anisms for suppression have been identified as well, including
direct suppression by the bZIP C/EBP family member CHOP
[GenBank:NM_007837.3] (Ron and Habener, 1992), titration of
the coactivator CRTC2 [GenBank:NM_028881.2] (Wang et al.,
2009), and translational regulation of the suppressive LIP isoform
of C/EBPβ [GenBank:NM_009883.3] (Li et al., 2008; Arensdorf
and Rutkowski, 2013). Each of these mechanisms was identified
through the behavior of target genes, so the extent to which any
of them contributes to global gene suppression is not clear.
In the liver, the most evident consequence of ER stress is
lipid accumulation (Rutkowski et al., 2008; Yamamoto et al.,
2010; Zhang et al., 2011). This lipid accumulation, or steatosis, is
accompanied by suppression of a host of genes involved in hepatic
lipid metabolic processes, including fatty acid oxidation, lipo-
genesis, cholesterologenesis, and VLDL production. Given that
some of these processes are mutually antagonistic (e.g., fatty acid
oxidation and lipogenesis), it seems likely that some are sup-
pressed as primary responses to ER stress, and others as secondary
consequences of feedback mechanisms.
Some regulation of hepatic lipid metabolism can be attributed
directly to the action of canonical UPR signaling. XBP1
can bind to the promoters and stimulate transcription of
lipogenic genes (Lee et al., 2008) and of the ER oxidore-
ductase PDI [GenBank:NM_001032.2] (Wang et al., 2012),
the latter of which stimulates VLDL secretion by virtue of
its interaction with the microsomal triglyceride transfer pro-
tein (MTTP) [GenBank:NM_001163457.1]. IRE1α can also
directly degrade mRNAs encoding lipogenic genes when Xbp1
is ablated through its regulated IRE1-dependent decay activ-
ity (So et al., 2012), thus acting at cross-purposes with its
downstream target XBP1. The ER-localized transcription fac-
tor CREBH [GenBank:NM_145365.3] also contributes to lipid
homeostasis (Zhang et al., 2012), although it is not yet clear
whether that function is direct or indirect.
Steatosis arises as a common phenotype in response to ER
stress when any of the UPR signaling pathways is ablated, or when
UPR signaling is intact but ER protein folding is compromised by
deletion of the ER cochaperone p58IPK [GenBank:NM_008929.3]
(Rutkowski et al., 2008). This steatosis is likely at least partially
caused by impaired secretion of triglyceride-rich VLDL parti-
cles from the stressed ER (Ota et al., 2008; Rutkowski et al.,
2008; Caviglia et al., 2011) and enhanced uptake (Jo et al., 2013).
However, ER stress also elicits extensive alterations in the expres-
sion of genes involved in lipid metabolism, and these alterations
are more severe and persistent when any branch of the UPR—
or when ER protein folding—is compromised (Rutkowski et al.,
2008). Thus, these alterations correlate with the development of
steatosis, although it is not known which events precede lipid
accumulation and which follow as a consequence. That they
emerge irrespective of which UPR pathway is ablated argues
that most such metabolic genes are not directly regulated by
ATF4, ATF6, or XBP1, but by some mechanism or mechanisms
that indirectly tie metabolic gene regulation to the ER stress
burden. To some degree the dysregulation of lipid metabolism
can be attributed to CHOP (Chikka et al., 2013), which is
redundantly regulated by each of the three UPR pathways and
which is expressed more robustly when stress is more severe—
as when the UPR or ER protein folding is disrupted (Rutkowski
et al., 2008). However, Chop−/− animals are only partially pro-
tected from hepatic steatosis during ER stress (Rutkowski et al.,
2008), suggesting that other as yet uncovered pathways exist
as well.
Given the extensive nature of metabolic gene regulation during
ER stress, there likely exists a mechanistic hierarchy of regulation,
with some metabolic genes being more proximally connected
to UPR pathways and others lying downstream of these initial
events. However, the global organization of lipid metabolic gene
regulation during ER stress has not been studied. Thus, our goal
in this work was to begin to decipher the structure of ER stress-
mediated metabolic gene regulation by establishing the temporal
progression of such events in the mouse liver, and to infer hierar-
chical relationships using a functional genomics approach, based
upon the behavior of coordinately regulated groups of genes in
wild-type mice vs. mice lacking the ER stress sensor ATF6α.
MATERIALS AND METHODS
ANIMAL EXPERIMENTS
All protocols for animal use were reviewed and approved by
the University Committee on Use and Care of Animals at the
University of Iowa or the University of Michigan. Animals were
bred in house, and were fed standard rodent chow and housed
in a controlled pathogen free environment with 12 h light and
dark cycles. Animals used were of varying ages and genders, with
control and experimental groups having similar composition.
Animals were fasted for 4 h prior to sacrifice, which was carried
out in daytime hours.
LIPID ANALYSIS
ADRP immunostaining was as described (Chikka et al., 2013).
For the trigylceride assay, a 100mg piece of liver was homog-
enized in 1mL of ice cold extraction buffer (1mM Tris pH
7.6, 1mM EGTA, 1mM MgCl2) containing protease inhibitors.
A 200μL aliquot of the homogenate was placed into a new
1.5mL tube on ice, and an additional aliquot was set aside to
determine the protein concentration of each sample. A 750μL
aliquot of a Chloroform:Methanol mixture (1:2 ratio) was added
to the 200μL homogenate sample and vortexed vigorously for
15 s. The samples were incubated at room temperature for
1 h, with the samples vortexed every 15min. Following the
hour incubation, 250μL of Chloroform was added to each
sample and vortexed for 15 s, then incubated at room tem-
perature for 15min. Two hundred μL of distilled water was
then added to the sample and vortexed as above. The sam-
ples were centrifuged at 5000 rpm for 10min, and the bottom
organic layer was collected and placed in a fresh tube. The
sample was evaporated under nitrogen gas, and the remain-
ing lipids were dissolved in 200μL of isopropanol. From
these samples, the triglyceride levels were determined using the
Infinity Triglycerides Reagent (Thermo Scientific, TR22421) per
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manufacturer’s instructions. The Cayman triglyceride standard
(Cayman Chemical, 10010509) was used to generate a standard
curve. Oil Red O staining was as described (Rutkowski et al.,
2008).
RNA ANALYSIS
The 8 h microarray has been published (Rutkowski et al., 2008).
For the 34 h microarray, mice were injected with 1mg/kg TM,
and mRNA was prepared from isolated livers and analyzed by
Affymetrix microarray in exactly the same way. The NCBI GEO
accession number for both arrays is GSE48939. Expression cat-
egories for each probeset are provided in Table S1. RT-PCR and
qRT-PCR analysis, including validation of all primer sets, was as
previously described (Rutkowski et al., 2006; Tyra et al., 2012),
except that gene expression was normalized against the average
expression of two housekeeping genes (Btf3 and Ppia) rather
than only one. Primer sequences can be found in (Rutkowski
et al., 2006, 2008; Wu et al., 2007; Tyra et al., 2012) and
Table S2.
BIOINFORMATIC ANALYSIS
Pathway enrichment analysis was performed using FunNet soft-
ware (Prifti et al., 2008). Data represent GO biological process
annotations with a decorrelated enrichment computation and a
5% false discovery rate correction. Transcription factor binding
site analysis was performed using oPOSSUM software (Ho Sui
et al., 2005). Data represent a single site analysis of vertebrate
transcription factor binding sites within 2000 base pairs upstream
or downstream of the transcription start site. The results of
this analysis were visualized using Cytoscape software. The net-
work was limited to genes with GO annotations involved in lipid
metabolism and transport using the BiNGO plug-in (Maere et al.,
2005).
CHROMATIN IMMUNOPRECIPITATION
Livers were isolated from 6–8 week-old mice and prepared for
ChIP using the ChIP Tissue Chromatin Shearing Kit with SDS
(Covaris). Samples were sonicated using a S220 focused ultrason-
icator (Covaris) to produce DNA bands between 100 and 1000 bp.
Following sonication, the immunoprecipiation was carried out
as described in (Arensdorf and Rutkowski, 2013) using HNF4α
antiserum (H-171, Santa Cruz) or non-specific IgG (12-370,
Millipore).
RESULTS AND DISCUSSION
SUPPRESSION OF METABOLIC TRANSCRIPTIONAL MASTER
REGULATORS PRECEDES LIPID ACCUMULATION DURING ER STRESS
Lipid accumulation can be induced in the liver by exposure
to the inhibitor of N-linked glycosylation tunicamycin (TM)
or the proteasomal inhibitor bortezomib, or by overexpression
of a misfolded ER client protein such as coagulation Factor
VIII [GenBank:NM_001161373.1] (Rutkowski et al., 2008; Zhang
et al., 2011; Chikka et al., 2013). Each of these treatments acti-
vates either the UPR or integrated stress response and each leads
to qualitiatively similar changes in the expression of keymetabolic
genes in the liver. These genes include both transcription factors
and cofactors involved in controlling metabolism as well as the
downstream targets of these factors that encode the key func-
tional enzymes involved in lipid catabolism, anabolism, storage,
and secretion (Rutkowski et al., 2008).
The temporal organization of these gene regulatory changes
prior and subsequent to the onset of lipid accumulation has not
been analyzed. It is likely that the earliest of these regulated events
are directly mechanistically connected to the UPR and/or inte-
grated stress response. Thus, we examined the time course of
hepatic lipid accumulation in wild-type mice in response to TM,
which is a more robust inducer of ER stress and steatosis than
other stimuli (Chikka et al., 2013). We monitored lipid accumu-
lation by three distinct criteria: accumulation of Oil Red O in
FIGURE 1 | ER stress causes substantial hepatic lipid accumulation
within 8h. (A) C57BL/6J mice were challenged with 1mg/kg TM for the
indicated times, livers were frozen in OCT, and lipids were stained with Oil
Red O. Scale bar = 50μm. (B) Same as (A), except lipid content was
assessed by immunohistochemical staining for the lipid droplet marker
protein ADRP. Scale bar = 50μm. (C) Same as (A), except triglyceride
content was measured by colorimetric assay after extraction of neutral
lipids. p < 0.001 by One-Way ANOVA. n = 3 samples per time point. Error
bars here and elsewhere show means ± SDM.
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lipid droplets of fresh frozen liver sections (Figure 1A); immuno-
histochemical detection of the lipid-droplet associated pro-
tein adipophilin (ADRP) [GenBank:NM_007408.3] (Figure 1B);
and direct biochemical assessment of hepatic triglyceride levels
(Figure 1C). Results from all three assays were similar: hepatic
lipid content increased most substantially at the 8 h time point.
Therefore, the key genetic regulatory events responsible for alter-
ing lipid metabolism are likely to occur prior to 8 h, while those
that occur later than 8 h after challenge are more likely secondary
effects that contribute to lipid disruption tangentially, if at all.
Next, we examined the timing of UPR activation and of
the regulation of metabolic genes. TM led to maximal IRE1α-
dependent splicing of Xbp1 mRNA within 2 h; this splicing
persisted through 8 h but was diminished at later time points
(Figure 2A). Likewise, every UPR-regulated target gene was
significantly upregulated by 2 h, peaked at 4–8 h, and diminished
thereafter (Figure 2B). These genes depend to varying extents
on activity of each of the three UPR pathways (Harding et al.,
2003; Lee et al., 2003; Wu et al., 2007). That they are uni-
formly upregulated by 2 h suggests that each of the three canoni-
cal UPR-regulated transcriptional activators—ATF6α, ATF4, and
XBP1—is functionally active by this very early time point.
We then analyzed expression of genes involved in lipid
metabolism, including both transcriptional regulators and key
rate-limiting metabolic enzymes. We grouped the genes accord-
ing to the time point at which they were first down-regulated.
We immediately observed that, in contrast to conventional UPR
target genes, the regulation of metabolic genes occurred in stages.
The earliest group regulated included select transcription factors
and cofactors. The coregulator Pgc1b [GenBank:NM_133249.2]
was downregulated by 2 h although not at 4 h (Figure 2C), mak-
ing the true timing of its suppression ambiguous. In contrast, by
FIGURE 2 | Staggered suppression of metabolic genes during ER stress.
(A) The spliced (spl) and unspliced (us) forms of Xbp1 mRNA were detected
by RT-PCR of total RNA isolated from the livers of mice treated with vehicle
(veh) or 1mg/kg TM for the indicated times. Each lane shows a separate
animal. Image is shown in black-to-white inverted form for greater visual
clarity. (B) Expression of the indicated UPR target genes was determined by
qRT-PCR from the animals shown in (A), with Btf3 and Ppia used as
normalizing controls. Expression here and in subsequent figures is given on a
log2 scale relative to the vehicle-treated condition. Here and elsewhere
unless noted: ∗p < 0.05; #p < 0.1 by two-tailed student’s t-test. (C–F)
Expression of metabolic genes was assessed by qRT-PCR as in (B), and
genes were grouped according to the time point at which downregulation
(p < 0.1) was first observed. The process in which each gene participates is
listed.
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4 h the coregulator Pgc1a [GenBank:NM_008904.2] and the tran-
scriptional activators Cebpa [GenBank:NM_007678.3] and Ppara
[GenBank:NM_001113418.1] were suppressed (Figure 2C).
PGC-1β contributes to lipogenesis, fatty acid oxidation, and
VLDL production and secretion (Lee et al., 2003; Lin et al., 2003,
2005a,b; Wolfrum and Stoffel, 2006), and PGC-1α contributes
to the latter two of these processes (Louet et al., 2002; Lin et al.,
2005a; Rhee et al., 2006). C/EBPα has general roles in energy
FIGURE 3 | Loss of Atf6α exacerbates steatosis and long-term metabolic
gene suppression. (A) Wild-type or Atf6α−/− mice were challenged with
1mg/kg TM or vehicle for 48 h, and ADRP immunostaining was carried out as
in Figure 1. Scale bar = 50μm. (B–F) Wild-type or Atf6α−/− mice were
challenged with 1mg/kg TM or vehicle for 34 h, and global mRNA expression
was assessed by Affymetrix microarray. Array-determined expression of the
indicated genes is shown. Genes were arranged in the same groupings as in
Figure 2. Statistical significance was calculated by two-tailed student’s t-test,
comparing expression in TM-treated Atf6α−/− animals against TM-treated
wild-type animals. n = 3 animals per group. (G) Mice were treated with TM
or vehicle for 48 h as in (A), and expression of the indicated genes was
determined by qRT-PCR. Significance was determined as in (B–F).
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homeostasis including lipid and glucose metabolism, while
PPARα is a master regulator of fatty acid oxidation (Desvergne
et al., 2006).
The genes downregulated at later times—i.e., after the onset
of pronounced lipid accumulation—included both transcrip-
tional regulators and downstream genes encoding rate-limiting
enzymes in metabolic processes, as indicated in Figures 2D–F.
These results suggest that PGC-1α, C/EBPα, and PPARα (and
possibly PGC-1β) are most likely the first lipid metabolic genes
regulated by ER stress. Further, the processes downstream of these
factors—namely, fatty acid oxidation and lipoprotein biogenesis
and transport—are the first affected via gene regulatory mecha-
nisms. In addition, because lipogenic genes are not altered until
much later (18 h), they suggest that inhibition of lipogenesis is a
secondary consequence of ER stress, perhaps occurring as a result
of negative feedback when lipids begin to accumulate. In addi-
tion, even though XBP1 splicing is induced by ER stress, we found
no evidence that lipogenic gene expression was stimulated under
these conditions.
DELETION OF ATF6α EXACERBATES METABOLIC GENE SUPPRESSION
Mice lacking ATF6α, while otherwise apparently normal and
healthy, exhibit dramatic steatosis upon challenge with TM
(Rutkowski et al., 2008; Yamamoto et al., 2010). This phenotype is
illustrated by ADRP staining in Figure 3A; it arises from an inabil-
ity to restore ER homeostasis upon challenge. Therefore, we rea-
soned that these mice could be used to expose the stress-regulated
gene expression changes that truly underlie lipid dysregulation,
since those changes should be amplified in Atf6α−/− animals. A
second benefit of these animals is that they can be used to identify
truly stress-responsive expression changes; those that result from
ER stress-independent properties of TM would not be expected
to differ between wild-type and Atf6α−/− animals, since ATF6α
is not thought to act outside the context of ER stress, and its dele-
tion does not alter the apparent pharmacological activity of TM
(Rutkowski et al., 2008).
We approached this goal by challenging wild-type and
Atf6α−/− animals for an extended period (34 h) with TM,
and then profiling global gene expression by microarray. We
chose this approach in part because we had previously used
microarray profiling to characterize gene expression in these
same mouse strains following 8 h of TM challenge (Rutkowski
et al., 2008). Conducting a second microarray study with an
identical gene chip at a later time point would provide us
with the unique opportunity to determine, for every gene
on the array, its expression in two different genotypes, under
two different treatment regimens (vehicle and TM) at two
different times.
By having 8 distinct combinations of experimental condi-
tions, we anticipated that we could begin to identify clusters of
coordinately regulated genes, including those metabolic genes
most responsive to ER stress. This relied upon the assump-
tion that genes which are part of a common functional path-
way (in this case, lipid metabolism) should be regulated simi-
larly. This approach has been used to great effect in yeast, and
more recently in cultured mammalian cells, to expose previ-
ously hidden components of the secretory apparatus and other
pathways of interest (Schuldiner and Weissman, 2013). Here, our
goal was to infer hidden transcriptional regulators using temporal
patterns of gene expression as an output.
From the 34 h microarray, we examined the expres-
sion of the UPR and metabolic genes shown in Figure 2.
Consistent with the role of ATF6α in contributing to chap-
erone expression (Wu et al., 2007; Yamamoto et al., 2007),
most ER chaperones and cochaperones known to be regulated
by ATF6α, such as Derl3 [GenBank:NM_024440.2], Erdj3
[GenBank:NM_001190804.1], Grp94 [GenBank:NM_011631.1],
p58IPK, and Erp72 [GenBank:NM_009787.2], were not upregu-
lated to as great an extent in Atf 6α−/− animals as in wild-type
animals (Figure 3B). Conversely, expression of Gadd34
[GenBank:NM_008654.2], which largely depends upon the
PERK axis of the UPR (Marciniak et al., 2004), was elevated
in Atf 6α−/− mice, consistent with persistent ER stress and
activation of the other limbs of the UPR.
Amongst the metabolic genes examined, none was
upregulated by ER stress in either genotype at 34 h.
Two genes—the lipogenic and cholesterologenic reg-
ulators Srebf1 [GenBank:NM_011480.3] and Srebf2
[GenBank:NM_033218.1]—were equally downregulated in
both genotypes (Figures 3D,E). However, the large majority
of genes were expressed at normal or near-normal levels in
wild-type animals, but deeply suppressed in Atf 6α−/− animals
(Figures 3C–F). qRT-PCR profiling of a sampling of these genes
from an independent experiment confirmed these findings
(Figure 3G). These data are consistent with the idea that acute
ER stress inhibits fatty acid oxidation and lipoprotein biogenesis
at the level of gene expression, and does not stimulate lipogenic
gene expression.
FUNCTIONALLY RELATED GENE GROUPS CLUSTER TEMPORALLY
Having these 8 distinct experimental conditions enabled us
to compare the global behavior of hepatic gene expression in
response to ER stress at early vs. late times in normal ani-
mals vs. those with a compromised UPR. A heatmap showing
TM-regulated genes makes two observations clear: First, gene
expression differences between the two genotypes were far more
extensive at 34 h than at 8 h. Second, at 34 h, many genes have
returned to normal or near-normal expression in wild-type ani-
mals, but have remained regulated, or become even more regu-
lated in the same direction, in Atf 6α−/− animals.
Each gene was then categorized based on whether it was upreg-
ulated, downregulated, or unchanged by ER stress in wild-type
and Atf 6α−/− animals after 8 or 34 h of stress. Thus, a gene
could fall into any of 81 (3 × 3 × 3 × 3) expression profiles. The
assignments for all probesets are provided in Table S1. We were
able to analyze the genes in this way in part because very few
genes differed in their basal (i.e., unstressed) expression between
genotypes; almost all genotype-dependent changes in expression
were caused by TM, so basal expression differences were not
confounding (Rutkowski et al., 2008).
Because Atf 6α−/− animals became more steatotic than wild-
type animals, genes that were not differentially expressed between
the two genotypes upon 34 h of TM treatment were not pursued
further, as these were unlikely to be major contributors to the
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FIGURE 4 | Clustering of genes according to temporal regulation in
wild-type andAtf6α−/− animals. (A) The expression of every probeset on the
Affymetrix microarray described in Figure 3was aggregated with expression
data from a previously published identical array comparing gene expression in
wild-type and Atf6α−/− animals 8 h after challenge with vehicle or 2mg/kg TM
(Rutkowski et al., 2008). For each time point, expression was determined using
a log2 scale relative to vehicle-treated wild-type animals at that time point. Only
probesets showing significant (p < 0.05) expression differences (1.5-fold, or
±0.58 on the log2 scale) in one or more of the four of the four conditions
(wild-type orAtf6α−/− at 8 or 34 h) are shown by heatmap, which accounted for
∼7000 of the ∼45,000 probesets on the array. Extent of up- or downregulation
is shown by intensity of red or blue coloration, respectively. Each column
depicts expression level averaged among the three animals per group. (B,C)
Every probeset on the array was characterized by its expression in the following
four ways, with differences defined as> 1.5-fold, p < 0.05: (1) up, down, or
unchanged in wild-type TM-treated animals at 8 h relative to vehicle-treated
wild-type; (2) up, down, or unchanged in Atf6α−/− TM-treated animals at 8 h
relative to TM-treatedwild-type; (3) same as (1) but 34 h; and (4) same as (2) but
34 h. The genes that showed a difference by criterion (4) were broken down into
groups based on their behaviorwith respect to these criteria, and the number of
genes in the nine most populated groups is shown in (B). The group of genes
that were upregulated by ER stress inwild-type animals at both time points, but
were less upregulated in Atf6α−/− animals—i.e., genes that could be
understood as directly ATF6α-dependent—is also accounted for. (C) provides a
key for illustration of gene expression patterns. (D–G) Expression pattern for
each of the gene groups shown in (B). These include genes shown in Figure 2
(those that did not fall into one of these groups are illustrated in Figure S1) as
well as genes involved in ER protein processing found in Group E. For genes
represented by more than one probeset, the behavior most commonly
represented and/or most consistent with qRT-PCR data is shown.
steatotic phenotype. Although 54 remaining combinations of
expression were possible (3 × 3 × 3 × 2), 90 percent of the
genes fell into only 9 categories (A–I, Figure 4B). Each cate-
gory of genes was then given a graphical representation of the
expression pattern of its members (Figures 4C–G). The two
most populated groups of genes (Groups A and B) were those
that were unaffected by stress at 8 h in either genotype, or in
wild-type animals at 34 h, but were up- or down-regulated,
respectively, at 34 h in Atf 6α−/− animals (Figure 4E). Among
the metabolic genes depicted in Figures 2, 3, a number of
these populate Group B, and they include genes encoding rate-
limiting enzymes in each pathway of fatty acid oxidation—Acox1,
Cpt1a, and Cyp4a10 [GenBank:NM_015729.3, NM_013495.2,
and NM_010011.3], which control peroxisomal, mitochondrial,
andmicrosomal oxidation, respectively. As the expression of these
genes is not altered until the later timepoint, they are unlikely to
be proximally connected to the UPR, but more likely represent
indirect effects—for example, of suppression of PPARα. The
next two most populated groups (Groups C and D) included
those genes that were either up- or down-regulated early in
both genotypes, and whose expression returned to normal lev-
els in wild-type animals by 34 h but which remained regulated in
Atf 6α−/− animals. Among metabolic genes, Group D included
the coregulators Pgc1a and Pgc1b. Closely related to these groups
were Groups E and F, which included genes that were up- or
downregulated early in both genotypes, and for which this reg-
ulation was enhanced in Atf 6α−/− animals at 34 h. The other two
rapidly regulated metabolic genes, Cebpa and Ppara, were found
in Group F.
The lipogenic genes Fasn [GenBank:NM_007988.3] and Acaca
[GenBank:NM_133360.2] and the cholesterologenic genes Acat2
[GenBank:NM_009338.3] and Hmgcr [GenBank:NM_008255.2]
showed no evidence of upregulation in the 8 or 34 h array data,
and Fasn and Acat2 were actually suppressed, as were Srebf1 and
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Srebf2 themselves (Figure S1). While lipogenesis can be stim-
ulated by non-transcriptional mechanisms—most notably pro-
cessing of SREBP-1c and SREBP-2—this processing would result
in stimulation of their downstream target genes, which is not
evidenced here.
Groups D and F were of the most interest to us because
they represented those genes most likely to be proximally mech-
anistically connected to UPR signaling, since they were regu-
lated rapidly by ER stress and since their long-term expression
coincided with the persistent ER stress and worsening lipid
accumulation seen in Atf 6α−/− animals. Group F in particular
was noteworthy because its counterpart cohort of upregulated
genes—Group E—included a number of genes known to be
direct targets of UPR transcription factors and which are thus
proximally connected to UPR signaling (Figure 2D).
Also supporting the validity of the approach was the group
of genes that were upregulated by ER stress in wild-type
animals at both time points, but that were not as upregu-
lated in Atf 6α−/− animals at both time points (Figure 4G).
These genes would fit the expected profile of direct targets of
ATF6α. While there were relatively few genes in this group, they
included those already described as direct ATF6α targets, includ-
ing Erp72, p58IPK, Erdj3, and Derl3 (Wu et al., 2007; Yamamoto
et al., 2007). This finding supports the idea that coregulated
genes can be discriminated based on their expression profile
in this setup.
This idea was reinforced by pathway analysis. The genes
from each of the ten groups (A–I and ATF6) were analyzed for
functional enrichments of Gene Ontology (GO) pathways using
FunNet (Prifti et al., 2008). As proof-of-concept, pathway analy-
sis of Group ATF6 genes yielded “unfolded protein response” as
the most significantly enriched process, which would be expected
of a group encompassing ATF6α direct targets (Figure 5A). Genes
representing processes relevant to lipid metabolism were enriched
in all of the downregulated groups—B, D, F, and G—but not
in the upregulated groups A, C, E, H, and I (Figures 5B,C).
Conversely, each of the upregulated groups was enriched in genes
representing pathways relevant to protein synthesis, trafficking,
and degradation. UPR activation during ER stress is known to
transcriptionally augment the cellular protein biogenesis machin-
ery through the action of the major UPR-regulated transcrip-
tional activators XBP1, ATF4, and ATF6 (Harding et al., 2003; Lee
et al., 2003; Wu et al., 2007). This pathway analysis thus suggests
that, at least in the liver, suppression of genes involved in lipid
metabolism represents a concerted focus of UPR activation.
FUNCTIONAL GENOMIC ANALYSIS IDENTIFIES HNF4α AS A PROXIMAL
REGULATOR OF METABOLIC GENE EXPRESSION DURING ER STRESS
We wished to harness the statistical power of our microar-
ray comparisons in order to predict regulatory transcription
factors whose activity was altered by ER stress; these would
be the most likely to be proximally mechanistically connected
to the UPR. To accomplish this, we subjected the genes in
each group to analysis using oPOSSUM (Ho Sui et al., 2005),
which searches the promoter/enhancer region of each gene for
consensus transcription factor binding sites from the JASPAR
CORE database. Establishing the validity of this approach, the
genes in Group ATF6 yielded the transcription factor NFYA
[GenBank:NM_001110832.1] as the sole statistically significant
hit (Figure 6A). ATF6α is known to dimerize with NFYA to regu-
late transcription from promoters containing ERSE and ERSE II
elements (Yoshida et al., 2000, 2001; Kokame et al., 2001). NFYA
was not enriched in any other group, underscoring the specificity
of the algorithm.
Because genes involved in lipid metabolism were found in
groups B, D, F, and G, we sought hits found in those groups and
no others, with a particular emphasis on groups D and F, since
these groups contain the early-responding genes. Remarkably,
binding sites for two transcription factors—HNF4α and NR2F1
[GenBank:NM_010151.2]—were enriched in Groups B, D, and
F but not in any other group (Figures 6B,C). These factors
have similar consensus binding sites (Kimura et al., 1993; Ellrott
et al., 2002; Schmidt et al., 2010), explaining why they segregate
together in this analysis. This finding suggests that the activ-
ity of these two transcriptional activators is altered during ER
stress, since genes containing binding sites for these factors are
downregulated by ER stress, and their downregulation is exacer-
bated by the ongoing stress seen in Atf 6α−/− mice. Conversely,
groups A, C, and E were enriched for genes with potential bind-
ing sites for ELK4, also known as SRF Accessory Protein (SAP)-1
[GenBank:NM_007923.2].
Group I, encompassing genes upregulated by long-term
ER stress in wild-type animals and further upregulated in
Atf 6α−/− animals, was enriched for binding by CREB1
[GenBank:NM_001037726.1], which shares a consensus bind-
ing sequence with the ER-localized transcription factor CREBH
(Zhang et al., 2006). CREBH is activated by proteolysis induced
by, among other stimuli, ER stress, and it regulates expression
of acute phase response genes and metabolic genes (Zhang et al.,
2006, 2012; Luebke-Wheeler et al., 2008). Accordingly, the genes
in Group I have a profile expected for CREBH targets—namely
that they are upregulated by ER stress, and further upregulated in
Atf 6α−/− animals, in which ER stress is exacerbated. However,
lipid metabolic genes were not enriched in Group I, and the
CREB1 binding site was not enriched in the groups containing
lipid metabolic genes. In addition, other than the gene encoding
serum amyloid P-component (Apcs) [GenBank:NM_011318.2],
most genes encoding acute phase response proteins (SAA pro-
teins, CRP, coagulation and clotting proteins, etc.) were not
significantly upregulated at either time point in either geno-
type, suggesting that CREBH activity during bona fide ER stress
(as opposed to endotoxin, pro-inflammatory cytokines, or other
stimuli) might be minimal, and the genes in Group I might
instead be regulated by another factor from the CREB family.
ELK4 is part of the Ternary Complex Factor (TCF) fam-
ily of transcription factors that interact with Serum Response
Factor (SRF) (Dalton and Treisman, 1992). A role for ELK4 in
hepatic gene expression has not been described, nor has ELK4
been directly linked to ER stress. ELK4 has been shown to be
activated by JNK-dependent phosphorylation (Janknecht and
Hunter, 1997), and JNK [GenBank:NM_016700.4] is activated
by ER stress (Urano et al., 2000). Thus, we speculate that ELK4
activity might be regulated during ER stress in the liver by JNK or
other MAP kinases to promote expression of genes in groups A,
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FIGURE 5 | Functionally related genes cluster by temporal regulation.
(A–C) Each of the gene groups in Figure 4 was subjected to Gene Ontology
pathway analysis using FunNet. The top seven most significant pathway
enrichments were then reordered by the number of genes from that group
that were pathway “hits,” with pathways having the most “hits” listed higher.
For reasons of space, five of these seven pathways from each group are
shown. In no case was a lipid metabolism process enriched among the
upregulated gene groups. In (B), pathways relevant to lipid metabolism are
listed in black, and other pathways in gray. In (C), pathways relevant to
protein processing are listed in black.
C, and E. NR2F1, also known as COUP-TF, is an orphan receptor.
Deletion leads to perinatal lethality with extensive dysregulation
of neuronal differentiation (Qiu et al., 1997). Its function in
the liver is less clear, although it has been shown to coactivate
transcription synergistically with HNF4α (Ktistaki and Talianidis,
1997; Yanai et al., 1999).
HNF4α is expressed most strongly in the liver, intestine, kid-
ney, and pancreas. Deletion is lethal during gastrulation (Chen
et al., 1994). Mice with a liver-specific deletion of HNF4α develop
steatosis concomitant with impaired ApoB and Mttp expres-
sion and VLDL production (Hayhurst et al., 2001). Hepatic
knockdown of HNF4α by adenoviral delivery resulted in steato-
sis and in impaired VLDL production, along with essentially
uniformly diminished expression of a host of genes involved
in lipid metabolism, including many of those reported here
(Yin et al., 2011). Thus, loss of HNF4α phenocopies many of
the lipid metabolic genetic changes that are induced by ER
stress. Overexpression of HNF4α in primary hepatocytes resulted
in upregulation of many of these same genes, though not of
Srebf1 nor Srebf2 (Yin et al., 2011). This exception is notable
because Srebf1 and Srebf2 are conspicuous among the metabolic
genes analyzed here in the fact that their downregulation is not
exacerbated at 34 h in Atf 6α−/− mice (Figures 3D,E). HNF4α
binding sites in the mouse liver genome have been characterized
by ChIP-seq (Schmidt et al., 2010), and genes in Groups B, D, and
F are confirmed HNF4α targets (Figure 6D).
Our results, together with the known activity of HNF4α, pre-
dict that ER stress leads to diminished activity of HNF4α, and that
this occurs as an early event in metabolic gene regulation by ER
stress. To test this prediction, we analyzed the binding of HNF4α
to ChIP-seq-defined sites in the promoter/enhancer regions of
three of the four earliest regulated metabolic genes—the tran-
scription regulators Cebpa, Pgc1a, and Ppara (the proximal Pgc1b
promoter/enhancer did not contain a predicted or validated
HNF4α binding site). We found that treatment of animals with
TM for 8 h did not change either the total expression (Figure 7A)
or nuclear localization (Figure 7B) of HNF4α. Yet, consistent
with our prediction, we found that HNF4α chromatin binding
decreased significantly at several sites in the Cebpa and Pgc1a
promoters upon treatment of animals with TM (Figure 7C).
This diminishment was not uniform; several sites within the
three promoters showed unaltered HNF4α binding (Figure 7A).
Together, these findings suggest that ER stress reduces the
activity of HNF4α at specific sites in the genome through
a mechanism that is independent of the HNF4α expression
level.
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FIGURE 6 | Transcription factor prediction implicates ELK4, HNF1α,
NR2F1, and HNF4α as hidden regulatory nodes in hepatic
stress-dependent gene regulation. (A–C) Each of the gene groups in
Figure 4 was subjected to oPOSSUM single-site analysis, which searches
regulatory regions (in this case, ±2000 bp from the transcriptional start site)
for potential binding sites of transcription factors identified in the JASPAR
CORE database. The results were limited to a Z -score > 10 and a Fisher
score < 0.01. (D) The data from (C) were visualized using the BINGO plug-in
for Cytoscape software, considering only genes relevant to lipid metabolism
as annotated from GO analysis. oPOSSUM-predicted binding sites are shown
using dashed lines, while genes with confirmed HNF4α-binding sites are
shown by solid lines.
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CONCLUSIONS
The hepatic lipid dysregulation that is elicited by ER stress is
accompanied by sweeping alterations to the expression of genes
involved in the process. With few exceptions, these genes are
downregulated by ER stress, and encompass numerous metabolic
pathways including fatty acid oxidation, lipogenesis, triglyceride
storage and secretion, and phospholipid synthesis. The down-
regulated genes include both those encoding the key enzymes of
each of these processes as well as the upstream transcription fac-
tors that regulate them. However, it would be unlikely that these
genes would be directly suppressed by canonical UPR-regulated
transcription factors, since these are, for the most part, tran-
scriptional activators rather than repressors. Further, ablation of
the ATF6α pathway of the UPR compromises recovery from ER
stress and leads to an exacerbated steatotic phenotype, yet ATF6α
does not directly act upon genes involved in lipid metabolism—
no such genes populate either group ATF6 or its downregulated
converse. Therefore, other mechanisms linking UPR activation to
metabolic gene regulation must be at work. The extensive nature
of metabolic gene regulation during ER stress also suggests a hier-
archical organization of gene regulatory events, with most genes
regulated as an indirect consequence of earlier events. Such an
organization predicted that the temporal ordering of gene regu-
lation could be used to identify the transcriptional events most
proximal to UPR signaling.
With these facts in mind, we hypothesized that a “bottom-up”
approach could be used to establish which ER stress-dependent
metabolic gene expression changes occurred earliest, and to
identify common regulators of those genes. To that end, our
analysis predicted altered activity of HNF4α, which we then
confirmed experimentally. We can conclude that its diminished
binding to the promoters of Cebpa and Pgc1a is likely to con-
tribute to the suppression of these genes, because knockdown
of HNF4α is already known to have similar effects on metabolic
genes to those reported here (Yin et al., 2011). We have combined
the experimental and bioinformatic experiments described here
with existing literature on the roles of HNF4α, C/EBPα, PGC-1α,
and PPARα into a working model describing the genetic hierar-
chy of lipid metabolic gene regulation during stress (Figure 8).
Although these relationships were elicited using TM, the observa-
tion that proteasome inhibition or overexpression of a misfolded
secretory protein leads to similar genetic changes and lipid accu-
mulation (Rutkowski et al., 2008), together with the fact that they
were elicited using animals with a specific lesion in ER stress
signaling, argue that they are likely to apply to ER stress in general.
Two key questions immediately arise for further study. The
first of these is whether all of the metabolic gene regulatory
changes downstream of ER stress are subordinate to HNF4α
and subsequent changes in the expression of just one or a
small number of rapidly suppressed master regulators such as
FIGURE 7 | Diminished HNF4α binding at Cebpa and Pgc1a
promoters during ER stress. (A,B) Wild-type mice were challenged
with 1mg/kg TM for 8 h, and expression of HNF4α was assessed by
immunoblot (A) or immunohistochemistry (B). Scale bar = 50μm. (C)
HNF4α binding to the regulatory regions of the indicated genes was
assessed by chromatin-IP. Regions are given relative to the transcriptional
start site, and correspond to regions identified by ChIP-seq analysis
(Schmidt et al., 2010). n = 3–4 animals per group. Typical recovery of
genomic material in samples containing HNF4α antibody was in the
range of 0.1–1 percent of total input. ∗p < 0.05 by t-test.
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FIGURE 8 | Model for organization of lipid metabolic gene regulation
during ER stress. Experimentally demonstrated (here or elsewhere)
relationships are shown using solid lines, while as-yet unvalidated
relationships suggested by this work are shown by dashed lines.
Cebpa, Pgc1a, etc. Testing this hypothesis requires systematic
overexpression of different metabolic transcriptional regulators,
to see which blunt lipid accumulation during ER stress and how
downstream metabolic genes respond. It is possible that HNF4α
regulates both the proximal transcriptional regulators (C/EBPα,
PGC-1α, etc.) and also genes encoding the downstreammetabolic
enzymes (CPT1A, ACOX1, etc.), which would provide a feedfor-
ward mechanism for suppression of these pathways. The second
question is how ER stress influences HNF4α activity. Absent
changes in HNF4α expression level or localization (Figure 7), the
most likely scenarios are either covalent modification of HNF4α
itself or modification, change in expression, or sequestration of a
binding partner of HNF4α.
It is possible that the preponderance of bZIP factors produced
during ER stress (ATF6α, ATF6β, ATF4, XBP1, and CHOP) could
titrate a coregulator away from HNF4α. Persistent ER stress expe-
rienced in Atf 6α−/− animals causes prolonged UPR activation
and expression of the other non-ATF6α UPR-regulated bZIPs
(Rutkowski et al., 2008), which might therefore cause continued
cofactor sequestration even as wild-type animals recover from
stress. A sequestration model predicts that the strength and per-
sistence of the stress will be a key factor in altering the activity of
non-UPR transcription factors like HNF4α. Accordingly, chronic
stresses would be expected to elicit different patterns of metabolic
gene regulation than acute stresses, and strong stresses different
patterns from milder ones. In support of this idea, exposure of
zebrafish larvae to chronic but mild TM results in efficient induc-
tion of steatosis in the larval livers, and knockdown of ATF6α
ameliorated this lipid accumulation. In contrast, a more acute but
stronger ER stress—perhaps most akin to the exposures used in
this work—led to less efficient steatosis that was exacerbated by
ATF6α knockdown (Cinaroglu et al., 2011). The effects of stresses
of different strengths and persistence have not yet been tested
in a mammalian system, and will be important in validating or
refuting the idea that pathophysiological conditions like obesity
are in effect states of chronic ER stress. We also note that this
work warrants an exploration of the roles of NR2F1 and ELK4
in hepatic gene expression. In fact, with all genes broken down
into 81 possible expression profiles, we predict that other testable
hidden regulatory nodes will emerge, and that searching these
groups for conserved sequences will reveal nodes beyond the rela-
tively small number that are linked to transcription factors in the
JASPAR CORE database.
Finally, the scope of this work was limited to exploring the
gene regulatory network linking acute ER stress to metabolism.
Our gene expression results suggest that genetic suppression of
VLDL production and fatty acid oxidation likely contribute to
the steatotic phenotype while lipogenesis does not contribute, and
might even be inhibited as a feedback mechanism to offset lipid
accumulation. However, it remains to be determined whether
these changes in mRNA expression are reflected in protein lev-
els and consequent biochemical activities of the various pathways,
and the extent to which they are also seen during physiological ER
stresses such as obesity.
In summary, we have provided proof-of-principle that a
bottom-up approach sheds light on the organization of metabolic
gene regulation during ER stress and makes testable predictions
about this organization. As a consequence, we have identified a
novel regulatory node in the process. Beyond revealing a likely
role for HNF4α in this regulation, it provides a resource for
regulators of other coordinated gene expression groups to be
discovered.
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